• Trevi Therapeutics (NASDAQ:TRVI) Earns Buy Rating from D. Boral Capital

    Source: Buzz FX / 24 Feb 2025 08:31:19   America/New_York


    Trevi Therapeutics (NASDAQ:TRVI) Earns Buy Rating from D. Boral Capital Written by MarketBeat February 24, 2025 Share Link copied to clipboard. Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) 's stock had its "buy" rating reiterated by
    Read more...
Share on,